-
公开(公告)号：US20210008265A1
公开(公告)日：2021-01-14
申请号：US17034250
申请日：2020-09-28
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/145 , A61B5/00 , A61M1/34 , A61M1/36 , A61M1/00 , A61M1/14 , B01D61/00 , B01D61/32 , A61B5/0295 , A61B5/053 , B01D65/02 , A61B5/026 , A61M1/28
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US10406268B2
公开(公告)日：2019-09-10
申请号：US15067559
申请日：2016-03-11
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , Suping Lyu , Bryant Pudil
IPC: A61M1/16 , A61M1/36 , B01D61/32 , B01D65/02 , A61M1/14 , A61M1/34 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/00 , A61B5/0295 , B01D61/00 , A61M1/28 , G06F19/00
Abstract: Monitoring of the performance of a blood fluid removal medium of a blood fluid removal device includes monitoring of condition, such as fluid flow rate or concentration of blood waste product, downstream of the medium. Upstream monitoring of the condition may also be performed to enhance the ability to determine whether the blood fluid removal medium is performing within predetermined ranges.
-
公开(公告)号：US10064985B2
公开(公告)日：2018-09-04
申请号：US15384912
申请日：2016-12-20
Applicant: MEDTRONIC, INC.
Inventor： Martin Gerber , Suping Lyu , Bryant Pudil
IPC: A61B5/00 , A61M1/16 , A61B5/145 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28 , B01D11/00
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patent parameters. By comparing the patient's current parameters to past parameters in response to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US09968721B2
公开(公告)日：2018-05-15
申请号：US14554338
申请日：2014-11-26
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M37/00 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
-
公开(公告)号：US20170100529A1
公开(公告)日：2017-04-13
申请号：US15384912
申请日：2016-12-20
Applicant: MEDTRONIC, INC.
Inventor： Martin Gerber , Suping Lyu , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patent parameters. By comparing the patient's current parameters to past parameters in response to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
Patent Agency Ranking
公开(公告)号：US20150151033A1
公开(公告)日：2015-06-04
申请号：US14613725
申请日：2015-02-04
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.
Abstract translation: 一种方法包括启动患者的血液流体清除会话; 在血液清除会话期间监测患者或其部分的组织液体体积的指标; 在血液清除期间监测患者的血液体积的指标; 确定组织液体体积指标与血液体积指标之间的比率是否超出预定范围; 以及如果所述比例被确定为在所述预定范围之外，则改变在所述血液流体清除会话期间的流体去除速率。 血液清除系统可以被配置为执行该方法。
-
公开(公告)号：US20150088047A1
公开(公告)日：2015-03-26
申请号：US14554272
申请日：2014-11-26
Applicant: MEDTRONIC, INC.
Inventor： Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
IPC: A61M1/16
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
Abstract translation: 一种方法包括通过传感器装置监测患者的流体体积的指示器，以及基于所监视的流体体积的指示器设定用于血液流体清除会话的初始流体体积去除处方。 该方法还可以包括将关于流体体积指示器的数据从可植入传感器装置传送到流体移除装置。 该系统包括被配置为设置初始流体去除体积和速率处方的血液流体清除装置。 在一些实施例中，流体移除装置基于从可植入传感器接收的数据设置或计算初始流体体积去除处方。 流体体积的指标可以是组织液体体积的指标或血液体积的指标。
-
公开(公告)号：US20170361006A1
公开(公告)日：2017-12-21
申请号：US15693535
申请日：2017-09-01
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/36 , A61B5/00 , A61B5/026 , A61B5/0295 , A61M1/28 , A61B5/145 , A61M1/00 , A61M1/14 , B01D65/02 , B01D61/32 , B01D61/00 , A61M1/34 , A61B5/053
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US09597440B2
公开(公告)日：2017-03-21
申请号：US14613725
申请日：2015-02-04
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M37/00 , C02F1/44 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.
-
公开(公告)号：US20150367054A1
公开(公告)日：2015-12-24
申请号：US14828990
申请日：2015-08-18
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
CPC classification number: A61M1/1601 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
-
-
-
-
-
-
-
-
Search Results
25
records
(took 0.03 seconds)
